1. Home
  2. ICD-10-PCS Index
  3. Administration
  4. Physiological Systems and Anatomical Regions
  5. Introduction
  6. 3E043GC
Version 2024
Billable Code

2024 ICD-10-CM Procedure Code 3E043GC

Introduction of Other Therapeutic Substance into Central Vein, Percutaneous Approach

ICD-10-PCS Code:
3E043GC
ICD-10-PCS Code for:
Introduce Oth Therap Subst in Central Vein, Perc
Is Billable?
Yes - Valid for Submission
Code Navigator:

3E043GC is a billable procedure code used to specify the performance of introduction of other therapeutic substance into central vein, percutaneous approach. The code is valid for the year 2024 for the submission of HIPAA-covered transactions.

3E043GC PCS Table

In an PCS table each code is represented by up seven alphanumeric characters, with each character in the table respresenting different aspects of the procedure. In the table provided below, each row represents an individual character and includes information about the character's position, designation, label, and procedure notes. For this PCS table the procedure code is in the administration section and is part of the physiological systems and anatomical regions body system, classified under introduction operation. The applicable bodysystem/region for this procedure code is central vein.

Position Designation Character Label Procedures Notes
1 Section 3 Administration
2 Body System E Physiological Systems and Anatomical Regions
3 Operation 0 Introduction

Involves:
Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products
4 BodySystem/Region 4 Central Vein  
5 Approach 3 Percutaneous

Involves:
Entry, by puncture or minor incision, of instrumentation through the skin or mucous membrane and any other body layers necessary to reach the site of the procedure
6 Substance G Other Therapeutic Substance Includes:
  • Idarucizumab, Pradaxa(R)(dabigatran) reversal agent
  • Praxbind(R) (idarucizumab), Pradaxa(R)(dabigatran) reversal agent
7 Qualifier C Other Substance

Replaced Code

3E043GC was replaced in the 2024 ICD-10-PCS code set with the code(s):

  • XW04306 - Introduce Brexanolone in Central Vein, Perc, New Tech 6
  • XW04306 - Introduce Brexanolone in Central Vein, Perc, New Tech 6
  • XW04306 - Introduce Brexanolone in Central Vein, Perc, New Tech 6
  • XW04306 - Introduce Brexanolone in Central Vein, Perc, New Tech 6
  • XW04308 - Introduce Spesolimab in Central Vein, Perc, New Tech 8
  • XW04308 - Introduce Spesolimab in Central Vein, Perc, New Tech 8
  • XW04326 - Introduce Nerinitide in Central Vein, Perc, New Tech 6
  • XW04326 - Introduce Nerinitide in Central Vein, Perc, New Tech 6
  • XW04326 - Introduce Nerinitide in Central Vein, Perc, New Tech 6
  • XW04326 - Introduce Nerinitide in Central Vein, Perc, New Tech 6
  • XW04357 - Introduce Narsoplimab in Central Vein, Perc, New Tech 7
  • XW04357 - Introduce Narsoplimab in Central Vein, Perc, New Tech 7
  • XW04357 - Introduce Narsoplimab in Central Vein, Perc, New Tech 7
  • XW04367 - Introduce Terlipressin in Central Vein, Perc, New Tech 7
  • XW04367 - Introduce Terlipressin in Central Vein, Perc, New Tech 7
  • XW04367 - Introduce Terlipressin in Central Vein, Perc, New Tech 7
  • XW04372 - Introduce Coag Factor Xa in Central Vein, Perc, New Tech 2
  • XW04372 - Introduce Coag Factor Xa in Central Vein, Perc, New Tech 2
  • XW04372 - Introduce Coag Factor Xa in Central Vein, Perc, New Tech 2
  • XW04372 - Introduce Coag Factor Xa in Central Vein, Perc, New Tech 2
  • XW04372 - Introduce Coag Factor Xa in Central Vein, Perc, New Tech 2
  • XW04377 - Introduce Trilaciclib in Central Vein, Perc, New Tech 7
  • XW04377 - Introduce Trilaciclib in Central Vein, Perc, New Tech 7
  • XW04377 - Introduce Trilaciclib in Central Vein, Perc, New Tech 7
  • XW04388 - Introduce Treosulfan in Central Vein, Perc, New Tech 8
  • XW04388 - Introduce Treosulfan in Central Vein, Perc, New Tech 8
  • XW04392 - Introduce Defibrotide in Central Vein, Perc, New Tech 2
  • XW04392 - Introduce Defibrotide in Central Vein, Perc, New Tech 2
  • XW04392 - Introduce Defibrotide in Central Vein, Perc, New Tech 2
  • XW04398 - Introduce Inebilizumab in Central Vein, Perc, New Tech 8
  • XW04398 - Introduce Inebilizumab in Central Vein, Perc, New Tech 8
  • XW043A3 - Introduce Bezlotoxumab in Central Vein, Perc, New Tech 3
  • XW043A3 - Introduce Bezlotoxumab in Central Vein, Perc, New Tech 3
  • XW043A3 - Introduce Bezlotoxumab in Central Vein, Perc, New Tech 3
  • XW043C6 - Introduce Eculizumab in Central Vein, Perc, New Tech 6
  • XW043C6 - Introduce Eculizumab in Central Vein, Perc, New Tech 6
  • XW043C6 - Introduce Eculizumab in Central Vein, Perc, New Tech 6
  • XW043C6 - Introduce Eculizumab in Central Vein, Perc, New Tech 6
  • XW043F3 - Introduce New Tech Therap in Central Vein, Perc, New Tech 3
  • XW043F3 - Introduce New Tech Therap in Central Vein, Perc, New Tech 3
  • XW043F3 - Introduce New Tech Therap in Central Vein, Perc, New Tech 3
  • XW043F3 - Introduce New Tech Therap in Central Vein, Perc, New Tech 3
  • XW043F3 - Introduce New Tech Therap in Central Vein, Perc, New Tech 3
  • XW043F5 - Introduce New Tech Therap in Central Vein, Perc, New Tech 5
  • XW043F5 - Introduce New Tech Therap in Central Vein, Perc, New Tech 5
  • XW043F5 - Introduce New Tech Therap in Central Vein, Perc, New Tech 5
  • XW043G5 - Introduce Sarilumab in Central Vein, Perc, New Tech 5
  • XW043G5 - Introduce Sarilumab in Central Vein, Perc, New Tech 5
  • XW043G5 - Introduce Sarilumab in Central Vein, Perc, New Tech 5
  • XW043G7 - Introduce Allogen CAR T in Central Vein, Perc, New Tech 7
  • XW043G7 - Introduce Allogen CAR T in Central Vein, Perc, New Tech 7
  • XW043G7 - Introduce Allogen CAR T in Central Vein, Perc, New Tech 7
  • XW043H5 - Introduce Tocilizumab in Central Vein, Perc, New Tech 5
  • XW043H5 - Introduce Tocilizumab in Central Vein, Perc, New Tech 5
  • XW043H5 - Introduce Tocilizumab in Central Vein, Perc, New Tech 5
  • XW043L7 - Introduce Lifileucel in Central Vein, Perc, New Tech 7
  • XW043L7 - Introduce Lifileucel in Central Vein, Perc, New Tech 7
  • XW043L7 - Introduce Lifileucel in Central Vein, Perc, New Tech 7
  • XW043W5 - Introduce Caplacizumab in Central Vein, Perc, New Tech 5
  • XW043W5 - Introduce Caplacizumab in Central Vein, Perc, New Tech 5
  • XW043W5 - Introduce Caplacizumab in Central Vein, Perc, New Tech 5
  • XW043W5 - Introduce Caplacizumab in Central Vein, Perc, New Tech 5
  • XW043W5 - Introduce Caplacizumab in Central Vein, Perc, New Tech 5

Clinical Classification

Convert to ICD-9-PCS

The following crosswalk between ICD-10-PCS to ICD-9-PCS is based based on the General Equivalence Mappings (GEMS) information:

Other ICD-10-PCS Codes Used for Introduction Central Vein

  • 3E04002 Introduction of High-dose Interleukin-2 into Central Vein, Open Approach
  • 3E04003 Introduction of Low-dose Interleukin-2 into Central Vein, Open Approach
  • 3E04005 Introduction of Other Antineoplastic into Central Vein, Open Approach
  • 3E0400M Introduction of Antineoplastic, Monoclonal Antibody, into Central Vein, Open Approach
  • 3E0400P Introduction of Clofarabine into Central Vein, Open Approach
  • 3E04016 Introduction of Recombinant Human-activated Protein C into Central Vein, Open
  • 3E04017 Introduction of Other Thrombolytic into Central Vein, Open Approach
  • 3E04028 Introduction of Oxazolidinones into Central Vein, Open Approach
  • 3E04029 Introduction of Other Anti-infective into Central Vein, Open Approach
  • 3E0403Z Introduction of Anti-inflammatory into Central Vein, Open Approach
  • 3E0404Z Introduction of Serum, Toxoid and Vaccine into Central Vein, Open Approach
  • 3E0406Z Introduction of Nutritional Substance into Central Vein, Open Approach
  • 3E0407Z Introduction of Electrolytic and Water Balance Substance into Central Vein, Open Approach
  • 3E040FZ Introduction of Intracirculatory Anesthetic into Central Vein, Open Approach
  • 3E040GC Introduction of Other Therapeutic Substance into Central Vein, Open Approach
  • 3E040GN Introduction of Blood Brain Barrier Disruption Substance into Central Vein, Open Approach
  • 3E040HZ Introduction of Radioactive Substance into Central Vein, Open Approach
  • 3E040KZ Introduction of Other Diagnostic Substance into Central Vein, Open Approach
  • 3E040NZ Introduction of Analgesics, Hypnotics, Sedatives into Central Vein, Open Approach
  • 3E040PZ Introduction of Platelet Inhibitor into Central Vein, Open Approach
  • 3E040RZ Introduction of Antiarrhythmic into Central Vein, Open Approach
  • 3E040TZ Introduction of Destructive Agent into Central Vein, Open Approach
  • 3E040VG Introduction of Insulin into Central Vein, Open Approach
  • 3E040VH Introduction of Human B-type Natriuretic Peptide into Central Vein, Open Approach
  • 3E040VJ Introduction of Other Hormone into Central Vein, Open Approach
  • 3E040WK Introduction of Immunostimulator into Central Vein, Open
  • 3E040WL Introduction of Immunosuppressive into Central Vein, Open
  • 3E040XZ Introduction of Vasopressor into Central Vein, Open Approach
  • 3E04302 Introduction of High-dose Interleukin-2 into Central Vein, Percutaneous Approach
  • 3E04303 Introduction of Low-dose Interleukin-2 into Central Vein, Percutaneous Approach
  • 3E04305 Introduction of Other Antineoplastic into Central Vein, Percutaneous Approach
  • 3E0430M Introduction of Antineoplastic, Monoclonal Antibody, into Central Vein, Percutaneous Approach
  • 3E0430P Introduction of Clofarabine into Central Vein, Percutaneous Approach
  • 3E04316 Introduction of Recombinant Human-activated Protein C into Central Vein, Percutaneous
  • 3E04317 Introduction of Other Thrombolytic into Central Vein, Percutaneous Approach
  • 3E04328 Introduction of Oxazolidinones into Central Vein, Percutaneous Approach
  • 3E04329 Introduction of Other Anti-infective into Central Vein, Percutaneous Approach
  • 3E0433Z Introduction of Anti-inflammatory into Central Vein, Percutaneous Approach
  • 3E0434Z Introduction of Serum, Toxoid and Vaccine into Central Vein, Percutaneous Approach
  • 3E0436Z Introduction of Nutritional Substance into Central Vein, Percutaneous Approach
  • 3E0437Z Introduction of Electrolytic and Water Balance Substance into Central Vein, Percutaneous Approach
  • 3E043FZ Introduction of Intracirculatory Anesthetic into Central Vein, Percutaneous Approach
  • 3E043GN Introduction of Blood Brain Barrier Disruption Substance into Central Vein, Percutaneous Approach
  • 3E043GQ Introduction of Glucarpidase into Central Vein, Percutaneous Approach
  • 3E043GR Introduction of Other Therapeutic Monoclonal Antibody into Central Vein, Percutaneous Approach
  • 3E043HZ Introduction of Radioactive Substance into Central Vein, Percutaneous Approach
  • 3E043KZ Introduction of Other Diagnostic Substance into Central Vein, Percutaneous Approach
  • 3E043NZ Introduction of Analgesics, Hypnotics, Sedatives into Central Vein, Percutaneous Approach
  • 3E043PZ Introduction of Platelet Inhibitor into Central Vein, Percutaneous Approach
  • 3E043RZ Introduction of Antiarrhythmic into Central Vein, Percutaneous Approach
  • 3E043TZ Introduction of Destructive Agent into Central Vein, Percutaneous Approach
  • 3E043VG Introduction of Insulin into Central Vein, Percutaneous Approach
  • 3E043VH Introduction of Human B-type Natriuretic Peptide into Central Vein, Percutaneous Approach
  • 3E043VJ Introduction of Other Hormone into Central Vein, Percutaneous Approach
  • 3E043WK Introduction of Immunostimulator into Central Vein, Percutaneous
  • 3E043WL Introduction of Immunosuppressive into Central Vein, Percutaneous
  • 3E043XZ Introduction of Vasopressor into Central Vein, Percutaneous Approach

What is ICD-10-PCS?

The ICD-10 Procedure Coding System (ICD-10-PCS) is a catalog of procedural codes used by medical professionals for hospital inpatient healthcare settings. The Centers for Medicare and Medicaid Services (CMS) maintain the catalog in the U.S. releasing yearly updates. The 2024 ICD-10-PCS codes are to be used for discharges occurring from October 1, 2023 through September 30, 2024.

Each ICD-10-PCS code has a structure of seven alphanumeric characters and contains no decimals. The first character defines the major "section". Depending on the "section" the second through seventh characters mean different things.